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1 
Introduction 
1.1 General overview of Medicinal plants 
Throughout the ages, humans have relied on Nature for their basic needs for the 
production of food-stuffs, shelters, clothing, means of transportation, fertilizers, 
flavours and fragrances, and, not the least, medicines. Plants have formed the basis of 
sophisticated traditional medicine systems that have been in existence for thousands 
of years and continue to provide mankind with new remedies. Although some of the 
therapeutic properties attributed to plants have proven to be erroneous, medicinal 
plant therapy is based on the empirical findings of hundreds and thousands of years. 
The first records, written on clay tablets in cuneiform, are from Mesopotamia and date 
from about 2600 BC; among the substances that were used were oils of Cedrus 
species (Cedar) and Cupressus sempervirens (Cypress), Glycyrrhiza glabra 
(Licorice), Commiphora species (Myrrh) and Papaver somniferum (Poppy juice), all 
of which are still in use today for the treatment of ailments ranging from coughs and 
colds to parasitic infections and inflammation (Fakim, 2006). 
Natural products have, until recently, been the primary source of commercial 
medicines and drug leads. A recent survey revealed that 61% of the 877 drugs 
introduced worldwide can be traced to or were inspired by natural products (Newman 
et al., 2003). However, beginning in the 1990s, natural product drug discovery was 
virtually eliminated in most big pharmaceutical companies. This was primarily due to 
the promise of the then-emerging field of combinatorial chemistry (Cseke et al., 
2004), whereby huge libraries of man-made small molecules could be rapidly 
synthesized and evaluated as drug candidates. 
Thus far, this approach has led to lukewarm results at best. From 1981 to 2002, no 
combinatorial compounds became approved drugs, although several are currently in 
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late-stage clinical trials. At the same time, the number of new drugs entering the 
market has dropped by half, a figure of which the large pharmaceutical corporations 
are painfully aware. The haystack is larger, but the needle within it is more elusive. 
This has led only recently to a newfound respect for the privileged structures inherent 
within natural products (DeSimone et al., 2004). 
Of the roughly 250,000 species of plants believed to exist, one-third of those have yet 
to be discovered. Of the quarter million that have been reported, only a fraction of 
them have been chemically investigated. Many countries have become aware of the 
value of the biodiversity within their borders and have developed systems for 
exploration as well as preservation. At the same time, habitat loss is the greatest 
immediate threat to biodiversity (Frankel et al., 1995). 
Products of natural origins can be called ‘‘natural products.’’ Natural products 
include: (1) an entire organism (e.g., a plant, an animal, or a microorganism) that has 
not been subjected to any kind of processing or treatment other than a simple process 
of preservation (e.g., drying), (2) part of an organism (e.g., leaves or flowers of a 
plant, an isolated animal organ), (3) an extract of an organism or part of an organism, 
and exudates, and (4) pure compounds (e.g., alkaloids, coumarins, flavonoids, 
glycosides, lignans, steroids, sugars, terpenoids, etc.) isolated from plants, animals, or 
microorganisms (Samuelsson, 1999). However, in most cases the term natural 
products refers to secondary metabolites, small molecules (mol wt <2000 amu) 
produced by an organism that are not strictly necessary for the survival of the 
organism. Concepts of secondary metabolism include products of overflow 
metabolism as a result of nutrient limitation, shunt metabolism produced during 
idiophase, defense mechanism regulator molecules, etc. (Cannell, 1998). Natural 
products can be from any terrestrial or marine source: plants (e.g., paclitaxel [Taxol] 
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from Taxus brevifolia), animals (e.g., vitamins A and D from cod liver oil), or 
microorganisms (e.g., doxorubicin from Streptomyces peucetius). 
Strategies for research in the area of natural products have evolved quite significantly 
over the last few decades. These can be broadly divided into two categories: 
1. Older strategies: 
a. Focus on chemistry of compounds from natural sources, but not on activity. 
b. Straightforward isolation and identification of compounds from natural sources 
followed by biological activity testing (mainly in vivo).  
c. Chemotaxonomic investigation. 
d. Selection of organisms primarily based on ethnopharmacological information, 
folkloric reputations, or traditional uses. 
2. Modern strategies: 
a. Bioassay-guided (mainly in vitro) isolation and identification of active ‘‘lead’’ 
compounds from natural sources. 
b. Production of natural products libraries. 
c. Production of active compounds in cell or tissue culture, genetic manipulation, 
natural combinatorial chemistry, and so on. 
d. More focused on bioactivity. 
e. Introduction of the concepts of dereplication, chemical fingerprinting, and 
metabolomics. 
f. Selection of organisms based on ethnopharmacological information, folkloric 
reputations, or traditional uses, and also those randomly selected. 
A generic protocol for the drug discovery from natural products using a bioassay-
guided approach is presented in Fig: 1.1. 
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Step 1: 
  
 
 
 
 
 
 
 
 
 
 
Step 2: 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plant material
Successive Soxhlet extraction 
withs solvent A, B and C Small scale 
Extract A Extract B Extract C 
Bioassay (in vitro) Bioassay (in vitro) 
One or more extracts: Active 
Plant material
Successive Soxhlet extraction 
withs solvent A, B and C Large scale 
Extract A Extract B Extract C 
Bioassay (in vitro) Bioassay (in vitro) 
Active extract (s) 
Bioassay (in vitro)
Preliminary fractionation by Flash 
chromatography/CC/VLC 
Active fraction (s) 
Different chromatographic techniques 
guided by in vitro assay 
Isolation and purification of 
compounds 
Active compound (s) 
Structure determination  
(UV, IR, MS, NMR, X-Ray etc.) 
Bioassay of active compound (s) using 
different concentrations to determine 
the potency 
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Fig. 1.1 An example of natural product drug discovery process (bioassay guided 
approach) 
 
1.2 Natural Products: Historical Perspective 
The use of natural products, especially plants, for healing is as ancient and universal 
as medicine itself. The therapeutic use of plants certainly goes back to the Sumerian 
civilization, and 400 years before the Common Era, it has been recorded that 
Hippocrates used approximately 400 different plant species for medicinal purposes. 
Natural products played a prominent role in ancient traditional medicine systems, 
such as Chinese, Ayurveda, and Egyptian, which are still in common use today. 
According to the World Health Organization (WHO), 75% of people still rely on 
plant-based traditional medicines for primary health care globally. A brief summary 
of the history of natural product medicine is presented in Table 1.1 
 
1.3 Current status of Natural Products 
Nature has been a source of therapeutic agents for thousands of years, and an 
impressive number of modern drugs have been derived from natural sources, many 
based on their use in traditional medicine. Over the last century, a number of top 
selling drugs have been developed from natural products (vincristine from Vinca 
 In vitro assay and 
toxicological studies Clinical trials 
Patent application 
Application for 
approval 
Pharmaceutical production and marketing 
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rosea, morphine from Papaver somniferum, Taxol from T. brevifolia, etc.). In recent 
years, a significant revival of interest in natural products as a potential source for new 
medicines has been observed among academia as well as pharmaceutical companies. 
Several modern drugs (~40% of the modern drugs in use) have been developed from 
natural products. 
 
Table 1.1 History of Natural Product Medicine 
Period Type Description 
Before 3000 
BC 
Ayurveda 
(knowledge of 
life) 
Chinese traditional medicine Introduced 
medicinal properties of plants and other natural 
products 
1550 BC Ebers Papyrus Presented a large number of crude drugs from 
natural sources (e.g., castor seeds and gum 
arabic) 
460–377 BC Hippocrates, 
‘‘The Father of 
Medicine’’ 
Described several plants and animals that could 
be sources of medicine 
370–287 BC Theophrastus Described several plants and animals that could 
be sources of medicine 
23–79 AD Pliny the Elder Described several plants and animals that could 
be sources of medicine 
60–80 AD Dioscorides Wrote De Materia Medica, which described 
more than 600 medicinal plants 
131–200 AD Galen Practiced botanical medicines (Galenicals) and 
made them popular in the West 
15th century Krauterbuch 
(herbals) 
Presented information and pictures of medicinal 
plants 
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More precisely, according to Cragg et al., 39% of the 520 new approved drugs 
between 1983 and 1994 were natural products or their derivatives, and 60–80% of 
antibacterial and anticancer drugs were from natural origins. In 2000, approximately 
60% of all drugs in clinical trials for the multiplicity of cancers had natural origins 
(Cragg et al., 1997). In 2001, eight (simvastatin, pravastatin, cvamoxycillin, 
clavulanic acid, azithromycin, ceftriaxone, cyclosporin, and paclitaxel) of the 30 top-
selling medicines were natural products or their derivatives, and these eight drugs 
together totaled US $16 billion in sales. Apart from natural product-derived modern 
medicine, natural products are also used directly in the ‘‘natural’’ pharmaceutical 
industry, which is growing rapidly in Europe and North America, as well as in 
traditional medicine programs being incorporated into the primary health care systems 
of Mexico, the People’s Republic of China, Nigeria, and other developing countries. 
The use of herbal drugs is once again becoming more popular in the form of food 
supplements, nutraceuticals, and complementary and alternative medicine. 
Interest in herbal drugs and natural medicine is undergoing a renaissance in the 
present age. Higher plant derived products represent around 25% of the total number 
of clinically used drugs (Bames et al., 2007). It has been reported that plants and other 
sources of natural products are superior sources of molecular diversity and novel 
molecular chemotypes, particularly in the areas where good synthetic leads do not 
exist (Raskin et al., 2002). Despite competition from other drug discovery methods, 
NPs are still providing their fair share of new clinical candidates and drugs. For 
example, between 1981 and 2002, 5% of the 1,031 new chemical entities approved as 
drugs by the US Food and Drug Administration (FDA) were natural products, and 
another 23% were natural-product-derived molecules (Newman et al., 2003) Fig: 1.2. 
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About 250000 living plant species contain a much greater diversity of bioactive 
compounds than any chemical library made by humans. 
 
         
 
 
“B”: Biological; usually a large (>45 residues) peptide or protein either isolated from an organism/cell 
line or produced by biotechnological means in a surrogate host. “N”: Natural product. “ND”: Derived 
from a natural product and is usually a semisynthetic modification. “S”: Totally synthetic drug, often 
found by random screening/modification of an existing agent. “S*”: Made by total synthesis, but the 
pharmacophore is/was from a natural product.“V”: Vaccine. “NM”: Natural product mimic. 
 
Fig: 1.2 All new chemical entities, 1981-2002, by source (Total =1031) 
 
Natural products can contribute to the search for new drugs in three different ways: 
1. By acting as new drugs that can be used in an unmodified state (e.g., vincristine 
from Catharanthus roseus). 
2. By providing chemical ‘‘building blocks’’ used to synthesize more complex 
molecules (e.g., diosgenin from Dioscorea floribunda for the synthesis of oral 
contraceptives). 
3. By indicating new modes of pharmacological action that allow complete synthesis 
of novel analogs (e.g., synthetic analogs of penicillin from Penicillium notatum). 
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Natural products will certainly continue to be considered as one of the major sources 
of new drugs in the years to come because: 
1. They offer incomparable structural diversity. 
2. Many of them are relatively small (<2000 Da). 
3. They have ‘‘drug-like’’ properties (i.e., they can be absorbed and metabolized). 
Only a small fraction of the world’s biodiversity has been explored for bioactivity to 
date. For example, there are at least 250,000 species of higher plants that exist on this 
planet, but merely 5–10% of these have been investigated so far. In addition, 
reinvestigation of previously studied plants has continued to produce new bioactive 
compounds that have drug potential. 
Much less is known about marine organisms than other sources of natural products. 
However, research up to now has shown that they represent a valuable source for 
novel bioactive compounds. With the development of new molecular targets, there is 
an increasing demand for novel molecular diversity for screening. Natural products 
certainly play a crucial role in meeting this demand through the continued 
investigation of the world’s biodiversity, much of which remains unexplored (Cragg 
and Newman, 2001a). With less than 1% of the microbial world currently known, 
advances in technologies for microbial cultivation and the extraction of nucleic acids 
from environmental samples from soil and marine habitats will offer access to an 
untapped reservoir of genetic and metabolic diversity (Cragg and Newman, 2001b). 
This is also true for nucleic acids isolated from symbiotic and endophytic microbes 
associated with terrestrial and marine macroorganisms. 
Discovery of vincristine and vinblastine (Fig 1.3) in 1963 by R. L. Noble and his 
Canadian co-workers (Neuss and Neuss, 1990) and its successful patent by Eli Lilly 
launched the pharmaceutical industry into the search for natural product leads for the 
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treatment of various cancers. Recent natural product discovery and development of 
avermectins (anthelmintic), cyclosporine and FK-506 (immunosuppressive), 
mevinolin and compactin (cholesterol-lowering), and Taxol and camptothecin 
(anticancer) (Fig. 1.3) have revolutionized therapeutic areas in medicine (Kirst et al., 
1992). Similar successful development of azoxystrobin (β-methoxyacrylate) 
fungicides and spinosad (tetracyclic macrolides) pesticides have created a renewed 
interest in natural product agrochemical discovery. Because biologically derived 
chemicals are perceived by consumers as having less environmental toxicity and 
lower mammalian toxicity, chemical and pharmaceutical companies currently have a 
greater desire to discover and develop natural product-based plant protectants. 
The versatility of plants in chemistry and biosynthesis is arguably unmatched by any 
other group of living organisms and potentially represents the most wide ranging 
source of novel pharmacologically active chemical entities in the living world. While 
the majority of natural products used therapeutically are derived from plants, it is 
argued that we have as yet only scratched the surface of what may be an Aladdin’s 
cave. This of course is true but we must strongly advocate expanding, not decreasing, 
the exploration of nature as a source of novel active agents that may serve as the leads 
and scaffolds for elaboration into desperately needed efficacious drugs for a multitude 
of disease indications. 
Advent, introduction, and development of several new and highly specific in vitro 
bioassay techniques, chromatographic methods, and spectroscopic techniques, 
especially nuclear magnetic resonance (NMR), have made it much easier to screen, 
isolate, and identify potential drug lead compounds quickly and precisely. Automation 
of these methods now makes natural products viable for high-throughput screening 
(HTS). 
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Paclitaxel (Taxol)    Vincristine  
 
                
 
Vinblastine      Avermectins 
 
            
Morphine        Camptothecin          Mevinolin 
 
             
    Cyclosporine        FK-506 
 
Fig: 1.3 Some drugs from natural sources 
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1.4 Overview of the Genus Rhododendron 
The genus Rhododendron (Ericaceae) consists of over 850 species, occurring 
throughout the world (Alan et al., 2010). An exhaustive survey of literature revealed 
that the different species of Rhododendron have a vast range of biological activities 
including anti-HIV, anti-inflammatory, anti-arthritic, anti-rheumatic, diaphoretic, anti-
hypertensive, hypotensive, diuretic, anti-asthmatic, cytotoxic, antibacterial, antifungal 
and antioxidant activity. Some very important bioactive molecules have been 
discovered from this genus, notably the anti-HIV rhododaurichromanic acid A, 
daurichromenic acid, hypotensive andromedotoxin and cytotoxic rhodomolleins and 
rhodojaponins. Terpenoids, flavonoids, coumarins, steroids, amines, phenolic acids 
and glycosides constitute major classes of phytoconstituents of the genus. 
Various species of Rhododendron offer an opportunity for bioprospection and need to 
be explored for the isolation of bioactive constituents for various biological activities, 
especially their effects on immune and circulatory and respiratory systems. 
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2.1 The Genus Rhododendron 
The generic name Rhododendron is derived from two Greek words “rhodon”, a rose, 
and “dendron”, a tree. It is a large genus of herbs, shrubs and trees, including some 
epiphytes and is distributed in the Northern hemisphere especially in temperate 
regions of North America, Europe and Asia with over 900 species,  600 of which 
grow in south to north of China- the Rhododendron emperor country (Alan et al., 
2010; Chinese Forestry Science and Technology Message, 1998). Maximum 
concentration of species occurs in the eastern Himalayas, China and Japan, extending 
into the mountains of South-East Asia. The genus has about 50 species in India (Singh 
et al., 2003) mainly distributed in the Himalayan region, of which only four occur in 
the Western Himalayas; a few exotics have also been introduced. Several 
Rhododendron species are widely cultivated for their diverse flower colours or 
evergreen foliage. Many hybrids have been raised and are extensively cultivated in 
Europe. 
 
2.1.1 Ethnopharmacology 
R. dauricum L. and R. aureum Georgi. are used in Tibetan medicine to treat several 
pathological conditions(Gammerman and Semichov, 1963) and as an expectorant to 
treat acute and chronic bronchitis  (Iwata et al., 2004; Kashiwada et al., 2001). The 
roots of R. dauricum are used for therapy of acute bacteroidal dysentery (Cao et al., 
2004). A decoction of R. luteum and R. ponticum leaves is externally used to treat 
fungal foot infection in Giresun province (Alan et al., 2010). The leaf of R. ellipticum 
is used in Taiwan as a folk medicine to treat high blood pressure (Chiu, 1987). The 
leaves and flowers of R. lepidotum are used as a snuff in headache (Dar et al., 2002). 
The leaves and flowers of R. ferrugineum are used for rheumatism in Germany 
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(Beauquesne et al., 1990). The leaves of R. campanulatum are mixed with tobacco 
and used as a snuff in the treatment of colds and headaches that affect only one side of 
the head (Chopra et al., 1986). The poulticed leaves of R. maximum are used to 
relieve arthritic pain, headaches etc (Usher, 1974; Foster and Duke, 1990). The 
flowers and leaves of R. latoucheae have been traditionally used to treat skin festers 
and the roots as a paregoric and antidote (Fan et al., 2001). R. barbatum has been used 
as fish poison (Chopra et al., 1957). The flowers and fruits of Rhododendron molle G. 
Don, a well-known poisonous plant, have been recorded in ancient and modern 
monographs as analgesics and insecticides (Li et al., 2000; Chen and Zheng, 1987). 
The roots, leaves and flowers of R. arboreum are important crude source of drugs in 
traditional system of medicine and are used in dysentery, fever and headaches 
(Swaroop et al., 2005; Chauhan, 1999). Rhododendron przewalskii Maxim. has been 
used as a folk medicine in China for the treatment of hypertension and coronary heart 
diseases (Li and Jia, 2003). R. ponticum, is a common folk medicine of the Black Sea 
region, widely used as analgesic for the treatment of rheumatic or dental pain, 
common colds and edema, both internally and externally (Baytop, 1999). The leaves 
and flowers of R. primulaeflorum are used to clear away heat, for detumescence, and 
tonification of kidneys. In Tibet and the western part of China, it is widely used to 
cure pulmonary disease, dropsy, indigestion, gastroptosis, and gastrectasis. The 
essential oils from it are used in curing chronic tracheitis (Li et al., 2010). The dried 
stems, leaves, and flowers of R. spinuliferum have been used as Chinese folk 
medicine for eliminating phlegm, relieving cough, and as an anti-asthmatic (Chen et 
al., 2009). The leaves and flowers of Rhododendron simsii have been used in Chinese 
medicine to treat irregular menstruation, traumatic injuries, rheumatism and 
subcutaneous swelling (Fenglin et al., 2004). 
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Rhododendrons are not only of high value in view but are also of good medicinal 
importance because of the essential oils present in their twigs, leaves and flowers and 
can be used as high grade spices and cosmetics, especially due to efficacies such as 
detoxification, relieving cough and calming asthma, dispelling phlegm, diminishing 
inflammation and depressing blood pressure (Jiangsu New Medicinal Academy, 2003; 
Kurokawa, 1995; Klingeman et al., 2000). In Tibet and China, the essential oils from 
various species of the genus Rhododendron are used to cure pulmonary diseases, 
laryngitis, urethritis, indigestion, gastroptosis, gastrectasis gastric cancer, hepatoma, 
dropsy and chronic tracheitis (Zhao et al., 2006; Klingeman et al., 2000). 
 
2.1.2 Phytochemistry 
Previous phytochemical work on genus Rhododendron has resulted in the isolation of 
various classes of compounds which is presented in the form of table 2.1. 
 
Table 2.1 Phytoconstituents of various species of Rhododendron. 
Species   Phytoconstituents 
R. adamsii  Essential oil (Fig. 1): α-pinene, β-pinene, β-myrcene, cis-β-
ocimene, isoledene, aromadendrene, humulene, β-farnesene, δ-
cadinene, trans-nerolidol, spathulenol, β-elemenone, and 
germacrone. (Rogachev et al., 2006) 
R. anthopogon quercetin-3-O-α-L-rhamnopyranoside, kaempferol, 24-
methylenecycloartenyl acetate, betulinic acid, ursolic acid, 
epifriedelinol, β-sitisterol, rutin, friedelin, quercetin (Joshi et 
al., 1981); 2, 6, 10, 14, 18, 22-tetracosahexaene, umbelliferone, 
3-hydroxy-3-phenylproponamide, orcin, quercetin, myricetin, 
myricetin-3-O-β-D-xylopyranoside, hyperin (Zhou et al., 
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2010a); Essential oil: N-acetyl-1, 2, 3, 4-
tetrahydroisoquinoline, 2-Ethoxypropane, 3-methyl-6-tert-
butylphenol, 3-Methyl-5-phenylisothiazole, diphenylamine, N-
ethyl-1, 2, 3, 4-tetrahydronaphthalenamine, pentacosane and 
tricosane (Zhou et al., 2010b) 
R. anthopogonoides  fatty acids and esters, terpenic alcohols and steroids (Liu, 2007) 
R. arboreum  rutin, coumaric acid, ursolic acid, epifriedelinol, friedelin, 
hyperin, quercetin, quercetin rhamnoside, taraxerol, betulinic 
acid, campanulin, α-amyrin, β-sitosterol, 3, 10- epoxyglutinane, 
flavone 5, 2- dihydroxy-7-methoxy-4-O- glucoside, dimethyl 
ester of terephthalic acid (Swaroop et al., 2005) 
R. aureum  Essential oil (Fig. 1): calarene, aristolene, burbonanes, 
cadinanes, trans-caryophyllene, aromadendrene, α-Selinene, 
Caryophyllene oxide, hexanoic acid, carvacrol, and α-pinene 
(Olennikov et al., 2009; Rogachev et al., 2006) 
R. bakeri  taxifolin-7-galactoside (King, 1977) 
R. barbatum   epifriedelinol, friedelin, β-amyrin, ursolic acid, n-triacontane, 
hentriacontanol, oleanolic acid, betulonic acid, 5, 6, 7, 4-tetra 
methoxyflavone, β-sitosterol (Bahuguna and Jangwan, 1987; 
Thapliyal and Bahuguna,1993) 
R. brachycarpum  campanulin, α-amyrin, β-amyrin, uvaol, simiarenol, ursolic acid 
and oleanolic acid (Youn and Cho, 1991) 
R. campanulatum campanulin, epifriedelinol, ursolic acid, quercitin, friedelin, α-
amyrin (King, 1977), oleanane triterpene (Tantry et al, 2011) 
R. capitatum Haplogenin (Batirov, 1980) 
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R. catawbiense quercetin 3-galactoside, sitosterol (Doss et al., 1982) 
R. chamaecistus  Gossytrin (Harborne, 1969; De Loose, 1970) 
R. championae  ursolic acid (Arthur and Hui, 1954b) 
R. cinnabarinum  ursolic acid, quercetin (King, 1977) 
R. collettianum 8-epi-cleomiscosin A, 8-O-β-D-glucopyranosyl-6-hydroxy-2-
methyl-4H-1- benzopyrane-4-one, cleomiscosin A, aquillochin, 
5, 6, 7- trimethoxycoumarin (Ahmad et al., 2004) 
R. concinnum  (2R)-farrerol-7-O-glucopyranoside, (2R, 3R)-(-)-
dihydroquercetin-3-O-β-D-xylopyranoside, (2S, 3S)-(-)-
dihydroquercetin-3-O-β-D-glucopyranoside, eriodictyol-7-O-β-
D-glucopyranoside, (2R, 3R)-(+)-dihydroquercetin (Zhao et al., 
2010); (2S)-4',5,7-trihydroxy-flavanone, (2R, 3R) (+)taxifolin, 
avicularin, quercetin-3-O-α-L-rhamnoside, hyperoside, 
quercetin, 19-kaurane acid, isoscopoletin, ledol, stigmast-4-en-
6β-ol-3-one, β-amyrin, α-amyrin, 28-hydroxy-β-amyrin, uvaol, 
oleanolic acid, β-sitosterol and β–daucosterol (Yang and Tian, 
2007) 
R. dauricum  rhododaurichromanic acid A, rhododaurichromanic acid B, 
daurichromenic acid, p-bromophenacyl rhododaurichromanic 
acid A, ursolic acid, oleanolic acid, daurichromenes A, B, C 
and D, confluentin, grifolin, orcinol, farrerol, quercetin, 
syringic acid, vanillic acid, 4-hydroxy benzoic acid and 
protocatechuic acid (Committee of Jiangsu New Medical 
College, 1995; Kashiwada et al., 2001; Iwata et al., 2004); 4, 5-
Dihydro-5-oxo-3-(p-tolyl) isoxazole, 1,3-Benzenediol, 5-
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methyl-2-(3, 7, 11-trimethyl-2, 6, 10-dodecatrienyl)-(E, E)-3, 6-
Diphenyl-1, 2, 3, 4, 5, 6, 7, 8-octahydro-1, 8-acridinedione, 6H-
[1, 2, 4] Triazolo [1, 5-a] indole, 4a, 5, 7, 8, 8a, 9-hexahydro-9-
methylene, 7-Amino-4-methyl-1, 8-naphthyridin-2-ol, 4-
Methyl-2, 6-dihydroxyquinoline, 2, 4, 6-triaminoquinazoline, 
2(1H) quinolinone, 4-hydroxy-1-methyl- (Mo-long and Tian-
miao, 2011); 1-menthol, β-sitosterol, tricosa tricosoate, 
docosanol, 1-heptadecanol, 3β,14-dihydroxy-oleanane-12-ene, 
octadecanoic acid, hyperin, quercetin-3-O-β-D-xylofuranoside 
(Fu et al., 2010); aavicularin, hyperoside (Mino et al., 2002); 
Essential oil (Fig. 1): trans-caryophyllene, -cadinene, β-
gurjunene, humulene, α-amorphene, limonene, α-pinene, p-
cymene, tetradecane, 1,2-benzenedicarboxylic acid, 
caryophyllene, caryophyllene oxide (Olennikov et al., 2009; 
Rogachev et al., 2006; Li et al., 2000) 
R. decipiens  campanulin, ursolic acid, friedelin, quercetin (Rangaswami and 
Sambamurthy, 1961) 
R. delavayi  3, 4, 7-trihydroxy-3, 5-dimethoxyflavone , 3, 4, 5, 7-
tetrahydroxy-3-methoxyflavone , quercetin-3-O-β-D-
arabinopyranoside, catechin, epicatechin, epicatechin-(2 
β→O→7, 4 β→8)-ent-epicatechin, (2S)-4-(3,4-
dihydroxyphenyl)-2-butanol, (3,4-dihydroxyphenol)-2-ethanol 
(Song et al., 2009) 
R. edgeworthii  Sesquiterpene-germacrone (Dass et al., 1980) 
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R. ellipticum  β-carotene, sitosterol, uvaol, quercetin, myricetin, quercitrin, 
myricitrin, hyperin, quercetin 3- glucoside, quercetin 5, 4-
dimethyl ether (Ho and Lin, 1995) 
R. falconeri  friedelin, α-amyrin, campanulin, betulinic acid, taraxerol, 
taraxeryl acetate, β-sitisterol, uvaol-3-acetate (Gupta et al., 
1969) 
R. farrerae  ursolic acid, cerin, farrerol (Arthur and Hui 1954b; Arthur et 
al., 1956) 
R. ferrugineum  phloracetophenone, phloracetophenone-4-glucoside, 
hyperoside, myricetin 3-O- β- galactopyranoside, kaempferol 3-
O-(6″-O-acetyl)-glucoside, quercetin 3-O-(6″-O-acetyl)-
glucoside, quercetin 3-O-(6″-O-acetyl)- galactoside, quercetin 
3-O-(3″,6″- O-diacetyl)-galactoside, trans-taxifolin 3-O-α-
arabinopyranoside, cis-taxifolin 3-O-α-arabinopyranoside  
(Chosson et al., 1998a & b) 
R. flavum  Essential oil: β-pinene, α-pinene, bornyl acetate, limonene, β-
elemene, sabinene, citronellol, myrcene, -terpinene, 
acoradiene, p-cymene and terpineol (Pu and Liang, 1999) 
R. formosanum  5, 6α -epoxy-5α -stigmastan-3β-ol, 5, 6β -epoxy-5β -
stigmastan-3β-ol (Krishna et al., 2006) 
R. formosum  leucocyanidin, epicatechin, dihydrotaraxerone, ursolic acid, 
taxifolin (King, 1977) 
R. grande  campanulin, friedelin, ursolic acid, dihydroflavonol, taxifolin, 
taraxeryl acetate, friedelin, taraxerol, β- sitosterol, betulinic 
acid, 2-acetyl-1- naphthol (King, 1977) 
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R. hodgsonsii  campanulin, friedelin, α and β-amyrin, uvaol, ursolic acid 
(King, 1977) 
R. irroratum  kaempferol, quercetin, myricetin, quercetin-3-O-β-D- 
galactopyranoside, quercetin -4-O- β-D-galactopyranoside 
(Yang and Kong, 2008) 
R. latoucheae  rhodolatouside A, rhodolatouside B, scandoside, galioside, 4-
(4-O-β-D- glucopyranosyl-3-methoxyphenyl)-2-butanone, 
dihydrodehydrodiconiferyl alcohol, 2-hydroxy-5-(2-hydroxy 
ethyl)- phenyl-O-β-D-gluco-pyranoside, tachioside, stratioside 
II, ursolic acid, daucosterol, β-sitosterol (Higuchi and Dervilla, 
1977; Jensen and Nielsen, 1982; Bianco et al., 1983; Shogo et 
al., 1987; Masataka and Masao, 1992; Fukuyama et al., 1996; 
Marina et al., 1996; Fan et al., 2001); (+)-rhodolatouchol, and 
isoepirhododendrin 4-[4-O-β-D-glucopyranosylphenyl]-2(S)-
butanol, were identified.  Six other known compds., (+)-
rhododendrol, epirhododendrin, 4-[3-O-β-D-glucopyranosyl-
4-hydroxyphenyl]-2-butanone, 4-(4-O-β-D-
glucopyranosylphenyl)-2-butanone, benzyl-O-β-D-
glucopyranoside, arbutin (Fan et al., 1999) 
R. lepidotum  rhodonin, rhodonetin (Khan et al., 2008); 7-O-β-D-
glucopyranosyl-8-methoxy benzopyranone , 7-hydroxy-8-O-β-
glycosyl benzopyranone , daphnetin (Ahmad et al., 2010); 
shamimarin, acetoxy-8-methyl-chromen-2H-one, daphnin, 
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daphnetin 8-O-b-D-glucopyranoside,  umbelliferone  (Tantry et 
al., 2010) 
R. luteum  Essential oil: β-caryophyllene, methyl benzoate, (E)-β-
ocimene, α-pinene, β-pinene, trans-methyl isoeugenol, benzyl 
alcohol, octadecanol, α-humulene, β-elemene; 
andromedotoxin (Alan et al., 2010) 
R. maximum  d-betuligenol, andromedotoxin (Wood et al., 1954; Tallent, 
1964) 
R. micranthum hyperin, astragalin, kaempferol, and quercetin. (Xia et al., 
1999) 
R. molle  everninic acid methyl ester-2-O-β-D-xylopyranosyl-(1→6)-β-
D-glucopyranoside, 7-hydroxy-5-methoxyphthalide-7-β-D- 
xylopyranosyl(1→6)-β-D- glucopyranoside, taraxerol, β-
sitosterol, rhodomolleins I, IX , X , XI , XII, XIII, XIV, XV, 
XVI, XVII, XVIII and XIX, grayanotoxin II, rhodojaponins II, 
rhodojaponins III, rhodojaponins VI, kalmanol, rhodomolins A 
and B (Kaiya and Sakakibara, 1985; Burke et al.,1989; Nishida 
et al.,1990; Klocke et al.,1991; Chen et al.,1992; Li et al., 
2000; Bao et al., 2002 ; Chen et al., 2004; Xiang et al., 2004; 
Zhong et al., 2005) 
R. mucronatum  Azalein, azaleatin (Wada, 1956) 
R. mucronulatum  scopoletin, (+)-taxifolin, quercetin, (-)-catechin, (+)-
epicatechin, scopolin, lyoniside, fraxin, (+)-lyoniresinol-3α-O-
β-D-glucopyranoside, (+)-taxifolin-3-O- α-L-arabinopyranoside 
and astragalin (Lee et al., 2005) 
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Fig. 2.1: Molecular structures of the major components of essential oils 
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R. nilagiricum friedelin, campanulin, ursolic acid, leucocyanidin (King, 1977) 
R. nivale  Essential oil: δ-cadinene, α-cadinol, cis, trans-farnesol, methyl 
carvacrol, α -cadinol isomer (Liu and Chen, 2008) 
R. niveum  β-sitisterol, vitexin, friedelin, hentriacontane, hentriacontanol, 
α- amyrin, epifriedelinol, quercetin-3- galactoside, quercetin-3-
glucoside (King, 1977) 
R. obtusum  azaleatin 3-galactoside (Horhammer et al., 1969) 
R. ovatum  3,5,7-trihydroxylchromone 3-O- β -D-xylopyranoside, 
taraxerol, β-sitosterol, betulinic acid, quercetin, quercetin-3-O- 
α -L- rhamnopyranoside, D-glucose (Feng et al., 2005) 
R. oveodoxa  grayanotoxin-I, grayanotoxin-N, 5,6-acetonyl grayanotoxin-I, 
5,6-acetonyl grayanotoxin-N and betuloside (Liu and Chen, 
1994) 
R. ponticum  catechin-(4α→6)-epicatechin (Fletcher, 1977); isoquercitrin, 
quercitrin, 6-C-glycosylnaringenin (Erdemoglu et al., 2008) 
R. primulaeflorum farrerol, 4,5,7-trihydroxy-8-methylflavanone, 
dihydrokaempferol, isorhamnetin, quercetin, hirsutine, 
reynoutrin, taxifolin-3-O-α-L-arabinopyranoside, (2R,3S)-
taxifolin-3-O-α-L-arabinopyranoside, (2S,3R)-taxifolin-3-O-α-
L-arabinopyranoside (Li et al., 2009); lyoniside, nudiposide, 
ssioriside, umbelliferone, scopoletin, isovanillin, noregenin, 
3,5,7-trihydroxychromone-3-O- α-L-arabinopyranoside, cis-
taxifolin, trans-taxifolin, (+)-catechin, (–)-epicatechin, 
proanthocyanidin A-1, proanthocyanidin A-2, avicularin, usinc 
acid, uvaol, ursolic acid, oleanolic acid, lupeol, β-sitosterol, and 
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daucosterol (Li et al., 2010); Essential oil: β-pinene, α-pipene, 
limonene, β-caryophyllene, myrcene, naphthalene, (+)-ledol,  
(+)-aromadendrene and α-terpineol (Wu et al., 2010) 
R. prunifolium  taxifolin 7-galactoside (King, 1977) 
R. przewalskii  rhododendrone, rhododendronside (Li and Jia, 2003) 
R. purdomii  quercetin 3-O-α-L-rhamnoside, hyperin, quercetin, scopoletin, 
α-amyrin, β-amyrin, oleanolic acid, β-sitosterol and β-
daucosterol (Liu et al., 2009) 
R. racemosum  kaempferol 5-methyl ether, kaempferol 5-methylether 3- 
galactoside (Harborne, 1969; De Loose, 1970) 
R. simiarum  ursolic acid, α-Amyrin, lupeol, simiarol, aromadendrin, 
quercetin (Arthur and Hui, 1954b; Arthur and Tam, 1960a) 
R. simsii  19, 24-dihydroxyurs-12-en-3-one-28-oic acid, 7-O-β-D-
apiofuranosyl- (1→6)-β-D-glucopyranosyl matteucinol, 3, 4-
dihydroxybenzoic acid, 3, 4-dihydroxybenzoate, matteucinol, 
azaleatin 3-galactoside, azaleatin 3-glucoside, azaleatin 3-
rutinoside, myricetin 5-methyl ether 3-galactoside, myricetin 5-
methyl ether 3- rhamnoside, cyanidin 3-galactoside-5-
glucoside, cyanidin 3-arabinoside-5-glucoside, matteucinol, 
ursolic acid, matteucinin (Arthur and Hui,1954a; Arthur and 
Tam,1960a; Asen and Budin, 1966; De Loose, 1969; 
Horhammer et al., 1969; De Loose, 1970; Takahashi et al., 
2001) 
R. spiciferum  quercetin-3-O-α-L-arabinfuranside, quercetin-3-O-α-L-
rhamnopyranoside, trans-taxifolin-3-O-α-arabinopyranoside, 
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astilbin, 3-O-rhamnoside engeletin, naringenin, (2S)-5,7,4-
trihydroxy-8-methylflavanone, epicatechin-(2 β→O→7,4 
β→8)-ent-epicatechin, proanthocyanidin A-1, bis-8, 8-
catechinylmethane, catechin and epicatechin (Wang et al., 
2010)  
R. spinuliferum  quercetin-3-0-[3″, 4″-O-(isopropylidene)-β-D-xylopyranoside], 
taxifolin, taxifolin 3-O-β-D-xylopyranoside, isoengeletin, 
astilbin and proanthocyarlidin A-2 (Luo et al., 2009); ursolic 
acid, oleanolic acid, quercetin, catechin, epicatechin, 
Umbelliferone, Scopoletin, Farrerol, (2S)-4, 5, 7-Trihydroxy-
8-methylflavanone, Myricetin, Dihydromyricetin, Kaempferol, 
Dihydrokaempferol, Isorhamnetin, Hirsutrin, Hyperin, 
Avicularin, Quercetin-3-O-α-D-arabinofuranoside, 
Kaempferol-3-O-α-D-arabinopyranoside, (2R, 3R)-Taxifolin-3-
O-α-D-arabinoside, (2S, 3R)-Taxifolin-3-O-α-D-arabinoside, 
(2R, 3S)-Taxifolin-3-O-α-D-arabinoside (Chen et al., 2009) 
R. speciosum  taxifolin 3-galactoside (King, 1977) 
R. thomsonii  andromedotoxin, cyanidin 3-galactoside, cyanidin 3- 
arabinoside (Harborne, 1962) 
R. veitchianum  ursolic acid, quercetin (King, 1977) 
R. westlandii  ursolic acid, epifriedelano1, friedelin, epoxyglutinane, α- and β-
amyrin, lupeol, myricetin, quercetin (Arthur and Hui,1954b; 
Arthur et al.,1956; Arthur and Tam,1960a; Arthur and Hui, 
1960b) 
R. wiltonii  ursolic acid, (+)-catechin, quercetin, kaempferol, 
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polystachoside and kaempferol-3-O-arabinoside (Hu et al., 
1990) 
R. yedoense  myricitin-5-methyl ether, quercetin-5-O-β-D-glucopyranoside, 
quercetin, quercitrin (Jung et al., 2007) 
 
 
2.1.3 Pharmacology 
Apart from their worldwide aesthetic and ethnic uses, several species have 
commercial and medicinal values (Leach, 1986). The dried leaves of R. dauricum are 
used medicinally as expectorant and in treatment of acute-chronic bronchitis (Jiangsa, 
1977; Yasuda et al., 1984). Methanol extract of the leaves and twigs of R. dauricum 
L. was found to display significant anti-HIV activity (EC50 ≤ 20µg/mL, TI >5) (Xiao, 
2002). Pathological experiments have demonstrated that farrerol and 8-
desmethlyfarrerol (Fig 2.2) from R. dauricum have significant ability to move the 
phlegm (Cao et al, 2004), hyperoside and isohyperoside can alleviate cough (Yin, 
1997), quercetin (Fig. 2.2), as a major active component of this plant, can prevent 
LPS-induced tumor necrosis factor-α and NO overproduction, which result in many 
immunomodulatory, infectious and inflammatory diseases such as sepsis syndrome, 
bacterial meningitis, cerebral malaria, adult respiratory distress syndrome, AIDS and 
rheumatoid arthritis (Manjeet and Ghosh, 1999; Morikawa et al., 2003). Aavicularin 
and hyperoside (Fig 2.2) from R. dauricum have antinociceptive action (Mino et al., 
2002).  
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Fig. 2.2: Molecular structures of the bioactive flavonoids 
 
Prenylated orcinol derivatives i.e., daurichromenes A-D, along with confluentin and 
grifolin (Fig 2.3) from R. dauricum have been found to show histamine release 
inhibitory effects, which can make them potential candidates in the treatment of 
inflammatory diseases (Iwata et al., 2004). Daurichromenic acid (Fig. 2.4) from R. 
dauricum has been found to possess potent anti-HIV activity with an EC50 value of 
0.00567 mg/mL and therapeutic index (TI) of 3.710. Rhododaurichromanic acid A 
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also shows relatively potent anti-HIV activity with an EC50 value of 0.37 mg/mL, and 
a TI of 91.9, whereas rhododaurichromanic acid B displays no anti-HIV activity 
(Kashiwada et al., 2001). The methanolic extract of its leaves and twigs was found to 
display significant anti-HIV activity (Kashiwada et al., 2001). 4-O-
Methylphloroacetophenone from R. dauricum has shown strong activity against all 
fungal species while as arbutin has an inhibitory effect on tyrosinase activity, and has 
been extensively used as a kind of skin-lightening agent in cosmetics (Cao et al, 
2004). 
Coumarins i.e., daphnin, daphnetin, daphnetin glucoside, rhodonetin, rhodonin and 
umbelliferone (Fig. 2.5) and their acetyl derivatives isolated from the methanolic 
extract of Rhododendron lepidotum have shown good antibacterial activity against 
Staphylococcus aureus, methicillin resistant Staphylococcus aureus, Escherichia coli, 
and Pseudomonas aeruginosa (Shakeel-u-Rehman et al., 2010). 
 
 
O
OH
H3C
OH  
Daurichromene A 
 
 
O
OH
H3C
OH  
Daurichromene B 
 
 
 
Chapter-2                        Review of Literature 
 
29 
O
OH
H3C
OH 
Daurichromene C 
 
 
O
OH
H3C
OH
 
Daurichromene D 
 
 
O
OH
H3C  
Confluetin 
 
 
OH
OH
H3C  
Grifolin 
 
Fig. 2.3: Molecular structures of histamine release inhibitory chemical 
constituents 
 
 
 
 
OMe
HO
O OH
Me
H
H
Me
   OMe
HO
O OH
Me
H
H
       OMe
HO
O OH
Me  
1           2     3 
 
 
 
Fiq. 2.4: Molecular structures of rhododaurichromanic acid A (1), 
rhododaurichromanic acid B (2) and daurichromenic acid (3) 
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Fig. 2.5: Molecular structures of the antibacterial coumarins 
 
A physiologically active substance andromedotoxin (acetylandromedol) (Fig. 2.6) 
present in leaves of Rhododendron maximum has shown potent hypotensive activity at 
very low concentrations. The same compound is believed to be responsible for the 
reported high toxicity of Rhododendron honey (mad honey) which indicates that the 
flowers may be a particularly rich source of andromedotoxin (Wood et al., 1954).  
Andromedotoxin exerts toxic effects by binding to sodium channels in cell 
membranes and increases the permeability of sodium ions in excitable membranes 
(Sutlupinar et al., 1993). The chemical compound rhodojaponin-III (Fig 2.6) isolated 
from R. molle has been shown to have significant blood pressure lowering and heart 
rate slowing effects (Li et al., 2000). Grayanane diterpenoids, rhodomolins A and B, 
together with diterpenoids, rhodomollein I and rhodojaponin III (Fig 2.6), isolated 
from the flowers of Rhododendron molle have shown significant cytotoxic activity 
against the Spodoptera frugiperda cell line Sf-9 (Zhong et al., 2005). 
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Fig. 2.6: Molecular structures of the bioactive diterpenes 
 
 
The ethanolic extract of R. arboretum possesses hypotensive effect. Its flowers are 
also used in dysentery, fever, headache and are known to possess anti-inflammatory 
activity (Agarwal and Kalpana, 1988). The flowers and leaves of R. ferrugineum are 
antirheumatic, diaphoretic and diuretic (Usher, 1974; Launert, 1981; Chiej, 1984). 
Leaves and flowers of R. latoucheae have been used to treat skin festers and the roots 
as antidote. The water extract of its leaves, used to treat chronic tracheitis, have 
shown antitussive and expectorant effects in clinical practice (Han, 1984). The 
methanol extract along with the chemical constituents of R. simsii showed potent 
antioxidative activity (Takahashi et al., 2001). An unusual oleanane triterpene (Fig 
2.7) isolated from the aerial parts of R. campanulatum has shown prominent 
antibacterial and immunomodulatory activities (Tantry et al., 2011). Courmarins 
isolated from R. collettianum are effective inhibitors of tyrosinase enzyme and have a 
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potential to be used for the treatment of hyperpigmentation associated with the high 
production of melanocytes (Ahmad et al., 2004). Sitosterol and quercetin 3-
galactoside from R. catawbiense have been found to be phagostimulants in nature 
(Doss et al., 1982). Tibetan medicine Dali, consisting of two Tibetan plants, R. 
anthopogonoides and R. primulaeflorum containing a mixture of essential oils, 
flavonoids and triterpenoids have been successfully used in eliminating phlegm, 
relieving cough, relieving inflammation, relaxing smooth muscle and curing asthma.  
As a clinical drug, it has also been used for treatment of chronic bronchitis and 
coronary artery disease (Li et al., 2008). Rhododendrons are a good source of 
pharmacologically active pentacyclic triterpenic acids like oleanolic acid, ursolic acid 
and betulinic acid (Fig 2.7) (King, 1977; Youn and Cho, 1991; Bahuguna and 
Jangwan, 1987; Thapliyal and Bahuguna,1993). Oleanolic acid and ursolic acid have 
been shown to act at various stages of tumor development to inhibit tumor initiation 
and promotion, as well as to induce tumor cell differentiation and apoptosis 
(Laszczyk, 2009). Oleanolic acid and ursolic acid are well known for their anti-HIV 
and hepatoprotective effects (Liu, 2005). Betulinic acid Shows a broad spectrum of 
activity against various cancer cell types (Schmidt et al., 1997) and is also known for 
its anti-HIV (Fujioka et al., 1994), anti-inflammatory (recio et al., 1995), 
antimicrobial (Schuhly et al., 1999), antimalarial (Bringmann et al., 1997), 
spasmogenic (Bejar et al., 1995), antinoceceptive (Kinoshita et al., 1998), 
antihelmintic (Enwerem et al., 2001), and anti-HSV-1 (Ryu et al., 1992) activities. 
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Fig. 2.7: Molecular structures of the bioactive triterpenoids 
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2.2 Coumarins 
Since the compounds isolated as a result of this research work were coumarins, a brief 
review of coumarins is given below. 
Coumarin, the simplest member of the group of oxygen heterocyclics called benzo-2-
pyrones, is represented by structure (1). They are lactones possessing a 2H-1-
benzopyran-2-one nucleus which opens on treatment with base to cis-O-
hydroxycinnamic acid and spontaneously re-cyclize on acidification. The skeleton (1) 
for coumarins was deduced by several researchers (Fittig, 1868; Strecker, 1868; 
Tiemann and Herzfeld, 1877). 
 
 
O O
1
2
3
45
6
7
8
9
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                                                               (1) 
 
 
Coumarins owe their class name to ‘coumarou’, the common name of the Coumarona 
odorata (syn. Dipteryx odorata) from which coumarin itself was isolated for the first 
time by Vogel in 1820. It is a large group of naturally occurring compounds widely 
distributed in many families of plants such as Asteraceae, Fabiaceae, Rosaceae, 
Rubiaceae, Solanaceae, particularly in the Umbelliferae and Rutaceae. More than 
1800 different natural coumarins have been discovered and described to date (Maes et 
al., 2008). 
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2.2.1 Classification 
A feature common to most coumarins is oxygenation at C-7 position. The 7-
hydroxycoumarin, commonly known as umbelliferone (2), is often regarded as the 
parent coumarin both structurally and biogenetically, of the more complex coumarins. 
Another common feature among coumarins is the presence of isoprenoid chains, 
frequently of one, but often of two or three units, attached to a carbon or oxygen or 
both. The prenyl group may be found as the simple 3-methylbut-2-enyl unit, but it is 
often encountered as the corresponding epoxide or vicinal glycol or in a variety of 
oxidized and skeletally rearranged forms (Murray et al., 1982). Biogenetically an 
additional heterocyclic ring can be formed when the prenyl group interacts with an O-
phenolic group. The structural variations of this type encountered in the natural 
coumarins mostly include dihydrofuran, hydroxydihydropyran and their derivatives, 
furan and dihydropyran. 
 
O OHO  
        (2) 
 
Prenylation at C-6 and C-8 can lead to linear coumarins such as psoralen (3) and 
xanthyletin (4) or angular forms like angelicin (5) and seselin (6) respectively.  
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O
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In this regard coumarins are classified as following: 
a) Simple, which includes coumarin, its hydroxylated, alkoxylated and alkylated 
derivatives and their glycosides 
b) Furanocoumarins, including the typical linear form psoralen and angular type 
angelicin 
c) Pyranocoumarins, which have a six membered ring attached to the benzoid part like 
seselin and xanthyletin 
d) Pyrone-ring substituted coumarins like 4-hydroxycoumarins and 3-
phenylcoumarins. 
 
2.2.2 Coumarins in Pharmaceutical and Chemical Industry 
Coumarins have attracted intense interest in recent years because of their diverse 
pharmacological properties. The presence of coumarins in plant extracts that have 
been used to treat human ailments is well known (Kostova, 2005). These plant 
extracts which were employed as herbal remedies in early days have now been 
extensively studied for their biological activities. These investigations have revealed 
their potentials as versatile biodynamic agents. For example, coumarins with phenolic 
hydroxyl groups have the ability to scavenge reactive oxygen species and thus prevent 
 
Chapter-2                         Review of Literature 
 
37 
the formation of 5-HETE (hydroxyeicosatetraenoic acid) and HHT (hydroxy 
heptadecatrienoic acid) in the arachidonic pathway of inflammation suppression 
(Kulkarni, et al., 2006; Kontogiorgis et al., 2006; Torres et al., 2006). Coumarin 
enhances the glycolytic enzymes and controls the glucose metabolism in the liver 
tissues of diabetic rats. Therefore, coumarin possesses antidiabetic activity by 
stimulating the insulin production from the existing β-cells of pancreas (Pari and 
Rajarajeswari, 2009). Naturally occurring coumarins possess a range of 
anticarcinogenic activities in rodent models. A recent study has shown that 7-
hydroxycoumarin inhibits the release of Cyclin D1, which is over expressed in many 
types of cancer. Several natural 5, 6, 7-trioxygenated coumarins have the capacity to 
induce cell differentiation in human leukemia U-937 cells which make them potential 
lead compounds in cancer therapy (Baez et al., 2005; Prince et al., 2009). Imperatorin 
and isoimperatorin, isolated from the umbelliferous Chinese crude drugs Tang-Bai-
Zai and Ashita-ba, possess strong antitumour promoter activity in cultured cells 
(Okuyama, et al., 1990). Coumarins have also inhibitory effect on DNA gyrase which 
may be linked to their anti-HIV activity (Kostova et al., 2006; Yu et al., 2003; Wu et 
al., 2001). Pyranocoumarins isolated from Clausena excavata and Zanthoxylum 
schinifolium exhibit anti-HBV activity (Tsai et al., 2000; Su et al., 2009). Some of the 
coumarins isolated from Angelica gigas exhibited significant protection against 
glutamate-induced toxicity in primary cultured rat cortical cells (Kang and Kim, 
2007). Coumarins are the classical anti-thrombotic agents. Oral anticoagulants of the 
4-hydroxycoumarin class of warfarin type are used worldwide to treat 
thromboembolic disease. They represent the platform upon which newer drugs 
holding the promise of greater efficacy and less toxicity are being developed. Even as 
new drugs arrive into clinical practice, coumarins remain remarkable for their 
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decades-long pre-eminence. They have saved countless lives and also served as 
essential probes into basic mechanisms of thrombosis. Testament to their clinical 
importance is that these agents are the only drugs profiled on a regular basis in special 
scientific statements by the American Heart Association/American College of 
Cardiology and by the American College of Chest Physicians (Mueller, 2004; Au and 
Rettie, 2008).  
Immunomodulatory activities of some coumarins have also been reported.  For 
example, isopimpinellin contributes to the immuno-enhancing activity of lymphocyte 
activation whereas bergapten, scoparone and xanthotoxin serve as candidates for the 
immuno-stimulating activity of IFN-γ secretion (Huang et al., 1992; Cherng et al., 
2008). Coumarins isolated from the aerial part of Artemisia capillaries showed 
antiplatelet aggregation activity (Wu et al., 2001). Coumarins also have good 
antimicrobial activity (Cespedes et al., 2006; Stein et al., 2006; Ostrov et al., 2007). A 
synthetic 8-Iodo-5, 6-dihydroxycoumarin has a MIC value close to that of the 
antibiotic vancomycin against MRSA (Smyth et al., 2009). Antimalarial activity has 
been addressed to daphnetin extracted from the plant Daphne as well as dentatin and 
clausarin isolated from Clausem harmandiana (Yang et al., 1992; Yenjai et al., 2000). 
Coumarin derivatives have also been shown to be novel lipid lowering agents that 
possess moderate triglyceride lowering activity (Madhavan et al., 2003). The 
bioactivities of phototoxic psoralens and of dicoumaroul derivatives are well known 
and several of these compounds are used in antipsoriatic therapy and anticoagulant 
therapy respectively. Besides psoriasis, skin diseases like cutaneous T-cell lymphoma, 
atopic dermatitis, alopecia areata, urticaria pigmentosa and lichen planus are treated 
with the photochemotherapy with linear furanocoumarins and UVA (Goodman and 
Gilman, 1996; Matern et al., 1999).  
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Coumarins like coumachlor and bromadiolone are potent and long-lasting 
commercially available rodenticides which last for a long time only with their single 
administration (Sato, 2005). According to Pillar, coumarin or its metabolic products 
have the potential to become the future treatement of scalds and other forms of 
thermal wounding because it facilitates the removal of extravasated protein through 
proteolytic by stimulated macrophages (Piller, 1997). Coumarins also reduce all high 
protein edemas, including lymphoedema and elephantiasis (Casley-Smith et al., 1993; 
Kontogiorgis et al., 2006). Some 3-alkyl and 3-phenyl isocoumarins have been 
reported to have diuretic and antihypertensive activities (Sassa et al., 1968).  
Coumarins have a wide variety of uses in industry, mainly due to its strong fragrant 
odour. Its uses include that of a sweetener and fixative of perfumes, an enhancer of 
natural oils, such as lavender, a food additive in combination with vanillin, a 
flavour/odour stabilizer in tobaccos, an odour masker in paints and rubbers and finally 
it is used in electroplating to reduce the porosity and increase the brightness of various 
deposits such as nickel. 6-Methylcoumarin is mainly used as a flavour enhancer and 
7-hydroxycoumarin in sunscreens (Egan et al., 1990). 
 
2.2.3 Biosynthesis 
The early studies on the biosynthesis of simple coumarins trace its origin in shikimic 
acid pathway via cinnamic acid. Shikimic acid was first obtained in 1885 from the 
plant Illicium religiosum (shikimi-no-ki) and has since been identified in many plants. 
The shikimic acid pathway is the major metabolic route leading to the formation of 
aromatic compounds in living systems. It operates both in microorganisms and in 
higher plants but not in animals, which is why the latter are dependent on dietary 
supply of the aromatic amino acids phenylalanine, tyrosine and trytophan. In addition 
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to providing these essential protein constituents, the shikimate pathway is necessary 
for the synthesis of essential factors like folic acid.  
Shikimic acid (7) is phosphorylated at the C-3 position, attachment of a 3-carbon side 
chain supplied by another molecule of phosphoenol pyruvate, followed by a 1, 4-
elimination of the elements of phosphoric acid leads to the formation of chorismic 
acid (8). Chorismic acid is converted into prephenic acid (9) via claisen 
rearrangement which after reductive amination is transformed into L-phenylalanine 
(10) (Scheme-1). The conversion of L-phenylalanine into trans-cinnamic acid (11) is 
catalysed by enzyme phenylalanine ammonia-lyase (PAL) in all vascular plants. The 
enzyme plays an important role in the metabolism of higher plants.  
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The shikimate pathway is involved in the formation of a vast array of so called 
secondary metabolites in plants and microorganisms like phenyl propanoids 
(coumarin), alkaloids, flavones, xanthones or many antibiotics. Cinnamic acid 
however represents a branch point in the biosynthesis of coumarin. There are many 
classes of coumarins, the biosynthesis of only the simple coumarins is described 
below. 
 
2.2.3.1 Simple coumarin (1) 
The simple coumarins are those in which the entire carbon skeleton has no ring 
additional to the benzopyrone nucleus. These can be further divided into two main 
groups: those with an oxygenated substituent at the C-7, e.g. umbelliferone (2) and 
herniarin (20) and those in which this substituent is absent, e.g. coumarin (1). 
Biosynthetic pathways leading to the formation of coumarins had been elaborated by 
Brown (1966) by using tracer experiments. Although the biosynthetic routes leading 
to 7-oxygenated and non-oxygenated coumarins are different in details, however the 
overall pathways have much in common. Scheme-2 illustrates the biosynthetic 
pathways for coumarin (1), while scheme-3 describes the biosynthesis of 
umbelliferone (2) and herniarin (20). The stage common in the biosynthesis of all 
coumarins from plant sources is the isomerization of trans-glucoside (13) to cis-
glucoside (14) as illustrated in schemes 2 and 3.  
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2.2.3.2 7-oxygenated coumarins 
O-hydroxycinnamic acid (12) and O-coumaryl glucoside (13) are selectively 
converted into coumarin (1) (Scheme-2), whereas p-coumaric acid (15) and 2-
glucosyloxy-4-methoxy cinnamic acid (21) are selectively converted into 
umbelliferone (2) and herniarin (20) (Scheme-3). That places cinnamic acid at a 
branching point of the biosynthetic sequence. The first step to herniarin (20) is a p-
hydroxylation of cinnamic acid while the first step to coumarin is an O-hydroxylation. 
It was also found that in the intact cell herniarin is predominantly present as a 
glycoside, presumably the cis-2-β-glycoside. The stage at which methylation occurs 
has not been determined with certainty. Studies of the biosynthesis of umbelliferone 
(2) gave analogous results (Torsell, 1997) (Scheme 3).  
The formation of di- and tri-hydroxycoumarins and of their ethers involves the 
hydroxylation of umbelliferone (2) rather than the lactonization of the corresponding 
cinnamic acids.  
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Scheme 3 
2.2.3.3 Furano and pyranocoumarins 
Prenylation of the benzene ring by dimethylallyl pyrophosphate in the 6- position of a 
7-hydroxycoumarin yields the so called linear furano and pyrancoumarins and in the 
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8- position it affords the angular homologues. The formation of furanocoumarins 
includes two successive steps: stereospecific oxidation and elimination of the 
hydroxyisopropyl residue by retroaldol condensation. Substitution in the 5- or 8- 
position or in both positions of furanocoumarins occurs later and is catalysed by 
oxidases and O- methyltransferases (Bruneton, 1999; Matern et al., 1999) (Scheme 4). 
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3. Results and Discussion 
3.1 RL-1 
RL-1 was obtained as sharp crystalline needles, melting point 225 °C. Mass spectrum 
showed the molecular ion peak at m/z 162 which corresponds to molecular formula 
C9H6O3. It gave characteristic greenish-blue spot under UV light and the absorption 
bands at 216, 245 and 322 nm in the UV spectrum, suggesting the presence of a 
coumarin skeleton (Murray et al., 1982). The IR spectrum exhibited the characteristic 
bands for -OH absorption at 3411 cm-1 and carbonyl absorption at 1680 cm-1. Its 
purity was checked both by TLC and HPLC (Fig. 3.1). 
 
 
 
 
Fig. 3.1: HPLC spectrum of RL-1 
 
 
The 1HNMR spectrum confirmed the presence of a coumarin skeleton, showing two 
doublets at δ 6.18 and 7.87 (each integrating for one proton, J = 9.5 Hz) attributed to 
H-3 and H-4 respectively and the signals at δ 7.51 and 6.84 (each integrating for one 
proton, J = 8.4 Hz) and a singlet at δ 6.72 attributed to protons of benzene aromatic 
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system. Further 13C–DEPT showed the presence of five methines and four quaternary 
carbons. RL-1 was positive to ferric chloride test and was thought to be phenolic 
which was supported by the chemical shifts of C-6, C-7 and C-8 in the 13C NMR 
spectrum (Table 3.1). It was further confirmed by the acetylation of RL-6 which 
yielded a monoacetate derivative, confirming the presence of a phenolic group. 
Finally RL-1 was characterized as Umbelliferone by comparison of spectral data 
(UV, IR, 1H and 13C NMR) with literature values and finally confirmed by Co-TLC 
and mixed m.p. with authentic sample (Reisch and Achenbach, 1992) (Fig. 3.2). 
 
Table 3.1: 1H and 13C NMR of RL-1 
Position δH δC DEPT 
2  - 162.0 C 
3  6.18 (1H, d, J = 9.5 Hz) 113.1 CH 
4  7.87 (1H, d, J = 9.5 Hz) 145.3 CH 
5  7.51(1H, d, J = 8.4 Hz) 130.7 CH 
6  6.84 (1H, dd, J = 8.4, 2.3 Hz) 114.1 CH 
7  - 157.2 C 
8  6.72 (1H, d, J = 2.3 Hz) 103.4 CH 
9  - 155.0 C 
10  - 112.9 C 
Coupling constants in Hertz are given in parenthesis 
Solvent used: MeOD 
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Fig. 3.2: Structure of RL-1 
 
3.1.1 Antimicrobial activity of RL-1 
RL-1 showed mild to poor antibacterial activity against the following bacterial strains: 
Gram positive Staphylococcus aureus ATCC 29213, MRSA ATCC 15187; Gram 
negative Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 9027 
obtained from American Type Cultures Collection. 
 
Table 3.2: Antibacterial activity of RL-1 against bacterial pathogens 
Organism Inhibitory zone MIC (μg/ml) 
RL-1 Standard 
S. aureus ATCC-29213 500 0.12 
MRSA ATCC-15187 1000 8.0 
E. coli ATCC-8739 1000 <0.03 
P. aeruginosa ATCC-9027 500 0.06 
 
3.2 RL-2 
RL-2 crystallized as colourless needles from methanol, melting point 255°C. The 
molecular ion peak at m/z 178 corresponded to molecular formula C9H6O4. Its purity 
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besides checking by TLC was also checked by HPLC (Fig. 3.3). The UV spectrum 
suggested it to be a coumarin as it was similar to those compounds already discussed 
in literature (Murray et al., 1982) with absorption bands at 218, 267 and 302 nm. It 
gave characteristic greenish-blue spot on silica gel coated TLC plates under UV light. 
Absorption bands for -OH at 3419 cm-1 and for carbonyl at 1725 cm-1 were exhibited 
in the IR spectrum of RL-2. 
The 1H NMR spectrum of RL-2 was quite similar to that of RL-4 except that the 
peaks for mannose moiety were absent. It showed four doublets of benzopyran 
nucleus (Table 3.3). The two doublets at δ 6.19 and δ 7.84 (each integrating for one 
proton, J = 9.4 Hz) were attributed to H-3 and H-4 respectively and the signals at δ 
7.00 (1H, J = 8.4 Hz) and δ 6.82 (1H, J = 8.4 Hz) were attributed to H-5 and H-6. In 
DEPT, 13CNMR showed the presence of four methines and five quaternary carbons. 
Acetylation of RL-2 yielded a diacetate derivative confirming the presence of two 
phenolic groups. 
 
 
 
Fig. 3.3: HPLC spectrum of RL-2 
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Finally RL-2 was identified as daphnetin on comparing its spectral data with that 
reported in literature (Thusoo et al., 1981) (Fig. 3.4). Daphnetin is reported to have 
antimalarial activity (Yang et al., 1992; Huang et al., 2006). 
 
O OHO
OH  
 
Fig. 3.4: Structure of RL-2 
 
 
Table 3.3: 1H and 13C NMR of RL-2 
Position δH δC DEPT 
2  - 160.1 C 
3  6.19 (1H, d, J = 9.4 Hz) 110.3 CH 
4  7.84 (1H, d, J = 9.4 Hz) 144.2 CH 
5  7.00 (1H, d, J = 8.4 Hz) 117.7 CH 
6  6.82 (1H, d, J = 8.4, Hz) 112.1 CH 
7  - 145.7 C 
8  - 130.1 C 
9  - 143.3 C 
10  - 111.2 C 
Coupling constants in Hertz are given in parenthesis 
Solvent used: MeOD 
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3.2.1 Antimicrobial activity of RL-2 
RL-2 showed good antibacterial activity against various bacterial strains. Gram 
positive Staphylococcus aureus ATCC 29213, MRSA ATCC 15187; Gram negative 
Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 9027 were used to 
test the activity. The cultures were maintained as per standard procedures. The 
antibacterial activity of the compound was expressed as minimum inhibitory 
concentration. 
 
Table 3.4: Antibacterial activity of RL-2 against bacterial pathogens 
Organism Inhibitory zone MIC (μg/ml) 
RL-2 Standard 
S. aureus ATCC-29213 125 0.12 
MRSA ATCC-15187 125 8.0 
E. coli ATCC-8739 500 <0.03 
P. aeruginosa ATCC-9027 500 0.06 
 
 
3.3 RL-3 
RL-3 was obtained as a whitish amorphous powder, melting point 185°C; [α]D25 62° 
(c 1.0, MeOH). It was assigned the molecular formula C16H18O9 (Fig. 3.5) as 
determined from ESI-MS, m/z at 354 which is supported by its elemental analysis and 
NMR data. Its purity was checked both by TLC and HPLC (Fig. 3.6). 
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Fig. 3.5: Structure of RL-3 
 
 
 
 
Fig. 3.6: HPLC spectrum of RL-3 
 
The IR spectrum showed the absorption bands of OH group (3463cm-1), a CO group 
(1724cm-1) and an aromatic moiety (1610 and 1578). The 1H NMR (Table 3.5) 
spectrum showed two doublets at δ 7.90 (1H, d, J = 9.5 Hz) and δ 6.28 (1H, d, J = 9.5 
Hz) and a quartet at δ 7.15 (2H, q, J = 8.6 Hz) besides other signals in nonaromatic 
range. In the aromatic region the 13CNMR and DEPT spectra (Table 3.5) showed 9 
signals in the range of δC 113 to δC 160 (aromatic region) and six resonances at δ 
103.3 (C-1'), 78.3 (C-3'), 76.7 (C-5'), 74.2 (C-2'), 70.9 (C-4'), 61.8 (C-6') (glycosidic 
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carbons) and a methoxyl carbon at δ55.3. From the above data the compound RL-3 
can be taken as a coumarin glycoside, in which the two doublets at δ 6.28 and 7.90 
account for H-3 and H-4 respectively. The proton resonances at δ 4.96 (1H, d, J 7.15 
Hz), 3.68-3.93 (3H, m), 3.52 (5H, m) are attributed to hexose and a methoxyl group. 
The above spectral data is more or less similar to that of Rhodonin except the signals 
in glycosidic region (Khan et al., 2008). The quartet at δ 7.15(2H, q, J = 8.6 Hz) is 
due to two protons at C-5 and C-6. Unlike that of Rhodonin which bears a pentose 
moiety at C-7, the glycan part in RL-3 can be clearly characterised as glucose on the 
basis of above 1H and 13C NMR spectrum. The coupling constant 7.1 Hz between H-
1 and H-2 and the 13C NMR value of anomeric carbon at δ103.3 indicates that the 
sugar moiety is attached to coumarin skeleton through β-linkage. Furthermore acidic 
hydrolysis of RL-3 afforded 7-hydroxy-8-methoxy coumarin which was identified by 
comparison of its 13C NMR and melting point with that reported in literature (Zhang 
et al., 2007). Thus the structure of RL-3 was elucidated as 7-O-β-D-glucopyranosyl-
8-methoxy benzopyranone. 
 
Table 3.5: 1H and 13C NMR of RL-3 
Position δH δC DEPT 
2  -  160.2 C 
3  6.28 (1H, d, J = 9.5 Hz)  113.2 CH 
4  7.90 (1H, d, J = 9.5 Hz)  145.2 CH 
5  7.15 (1H, d, J = 10.57 Hz) 118.9  CH 
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6  7.14 (1H, d, J = 10.57 Hz) 114.3  CH 
7  -  149.1 C 
8  - 135.2  C 
9  - 143.6  C 
10  - 115.5  C 
1' 4.96 (1H, d, J = 7.15 Hz) 103.3 CH 
2' 3.68 (1H, m) 74.2 CH 
3' 3.71 (1H, m) 78.3 CH 
4' 3.93 (1H, m) 70.9 CH 
5' 4.21 (1H, m) 76.7 CH 
6' 3.52 (2H, m) 61.8 CH2 
-OMe 3.52 (3H, m) 55.3 CH3 
Coupling constants in Hertz are given in parenthesis 
Solvent used: DMSO (d6) 
 
3.3.1 Antimicrobial activity of compound RL-3 
RL-3 showed mild to poor antibacterial activity against the following bacterial 
strains: Gram positive Staphylococcus aureus ATCC 29213, MRSA ATCC 15187; 
Gram negative Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 
9027 obtained from American Type Culture Collection. 
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Table 3.6: Antibacterial activity of RL-3 against bacterial pathogens 
Organism Inhibitory zone MIC (μg/ml) 
RL-2 Standard 
S. aureus ATCC-29213 250 0.12 
MRSA ATCC-15187 250 8.0 
E. coli ATCC-8739 500 <0.03 
P. aeruginosa ATCC-9027 500 0.06 
 
 
3.4 RL-4 
RL-4 was obtained as a yellow powder, melting point 195 °C; [α]D25  25° (c 1.0, 
MeOH).  Its molecular formula was determined as C15H16O9 on the basis of ESI-MS 
peak at 363 [M+Na]+ which was confirmed by elemental analysis. The purity of the 
compound was checked both by TLC and HPLC (Fig. 3.7) 
 The IR (KBr) spectrum showed the absorption bands of OH group (3535 cm-1), a CO 
group (1723 cm-1) and an aromatic moiety (1613, 1579 cm-1). The UV spectrum with 
max at 220nm and 368nm correspond to a coumarin nucleus. The 1H NMR spectrum 
showed four equivalent doublets in the aromatic region at δ 7.78 and δ 6.14 (J = 9.5 
Hz) and δ 7.20 and δ 6.79 (J = 8.6 Hz). This 1H NMR spectrum is quite similar to that 
of daphnetin except a singlet at δ 4.68 (1H) and two multiplets at δ 3.63-3.73 and δ 
3.34-3.38 (equivalent to 3H each). These signals can be attributed to a hexose moiety. 
The nature of the sugar moiety was determined by hydrolyzing RL-4 with 1.0N HCl 
and comparing its 1H NMR values with that of mannose. Thus the structure of RL-4 
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was elucidated as 7-hydoxy-8-O-β-D-mannosyl benzopyranone and is shown in Fig. 
3.8. 
 
 
 
 
Fig. 3.7: HPLC spectrum of RL-4 
 
 
 
 
 
Fig. 3.8: Structure of RL-4 
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Table 3.7: 1H and 13C NMR of RL-3 
Position δH δC DEPT 
2  -  161.8 C 
3  6.14 (1H, d, J = 9.5 Hz)  113.5 CH 
4  7.78 (1H, d, J = 9.5 Hz)  145.0 CH 
5  7.20 (1H, d, J = 8.6 Hz) 124.5  CH 
6  6.79 (1H, d, J = 8.6 Hz) 111.3  CH 
7  -  154.1 C 
8  - 131.6 C 
9  - 147.9 C 
10  - 112.7 C 
1' 4.68 (1H, s) 105.3 CH 
2' 3.73 (1H, m) 74.1 CH 
3' 3.63 (1H, m) 77.1 CH 
4' 3.34 (1H, m) 69.5 CH 
5' 3.67 (1H, m) 76.4 CH 
6' 3.38 (2H, m) 60.8 CH2 
Coupling constants in Hertz are given in parenthesis 
Solvent used: DMSO (d6) 
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3.4.1 Antimicrobial activity of compound RL-4 
RL-4 showed mild to poor antibacterial activity against the following bacterial 
strains: Gram positive Staphylococcus aureus ATCC 29213, MRSA ATCC 15187; 
Gram negative Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 
9027 obtained from American Type Cultures Collection. 
 
Table 3.8: Antibacterial activity of RL-4 against bacterial pathogens 
Organism Inhibitory zone MIC (μg/ml) 
RL-2 Standard 
S. aureus ATCC-29213 250 0.12 
MRSA ATCC-15187 250 8.0 
E. coli ATCC-8739 250 <0.03 
P. aeruginosa ATCC-9027 500 0.06 
 
 
3.5 Antibacterial activity of the extracts of Rhododendron lepidotum 
The three extracts namely A001 (ethanol), A002 (1:1 ethanol/water) and A003 (water) 
of Rhododendron lepidotum were tested against following bacteria: Gram positive 
Staphylococcus aureus ATCC 29213, MRSA ATCC 15187; Gram negative 
Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 9027 obtained 
from American Type Cultures Collection. Ciprofloxacin was used as a standard 
antibacterial agent for this study. The antibacterial activity of the compound was 
expressed as minimum inhibitory concentration (MIC). Both A001 and A002 extracts 
showed good inhibitory effect against Staphylococcus aureus ATCC 29213, MRSA 
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ATCC 15187 and moderate inhibitory effect against Escherichia coli ATCC 8739 and 
Pseudomonas aeruginosa ATCC 9027. However A003 failed to show any significant 
activity against any of the tested pathogens. 
 
Table 3.9: Antibacterial activity of the extracts of R lepidotum against bacterial 
pathogens 
Organism Inhibitory zone MIC (μg/ml) 
A001 A002 A003 Standard 
S. aureus ATCC-29213 250 1000 >2000 0.12 
MRSA ATCC-15187 500 1000 >2000 8.0 
E. coli ATCC-8739 1000 2000 >2000 <0.03 
P. aeruginosa ATCC-9027 1000 2000 >2000 0.06 
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Chapter-4                                   Experimental 
 
59 
4. Experimental 
4.1 Materials and Methods 
Melting points are uncorrected and were determined in glass capillary tubes using 
Buchi B- 545 melting point apparatus. Optical rotations were measured using 
Rudolph Autopol IV digital polarimeter. UV spectra were scanned in methanol on 
specord S100. Infrared spectra were recorded as KBr pellets in cm-1 on a Hitachi 270-
30 spectrophotometer. 1H NMR and 13C NMR, HMBC were recorded on 200 and 500 
MHz Bruker Daltonics spectrometers respectively. The chemical shifts (δ) are 
reported in ppm relative to tetramethylsilane (TMS) as internal standard and coupling 
constants were measured in Hz using deuterated methanol and DMSO as solvents and 
TMS as internal standard. Mass spectra were recorded by using a Bruker Daltonics 
electrospray ionization. Thermo Finnegan HPLC system consisting of high pressure 
liquid chromatography pump (P-4000), an auto sampler (AS-3000), a column oven, a 
diode array detector (UV-6000 LP), vacuum membrane degasser (SCM-1000), system 
integrator (SN-4000) and RP-18 (250mm x 4.6mm; particles 5μm; Merck Germany) 
was used for checking the purity of compounds. Column chromatography was carried 
out on silica gel (Merck, 60-120 and 120-240 mesh). The purity of samples was 
checked on precoated silica gel plates (Merck). Acetic anhydride, pyridine and 
dimethylamino pyridine (DMAP) were used for acetylation. Solvents of LR grade 
(Merck) were used for chromatographic isolation.  
Thin layer chromatographic (TLC) plates were visualised under ultraviolet light at 
254 nm for fluorescence quenching spots and at 366 nm for fluorescent spots. Cerric 
sulphate, sulphuric acid and FeCl3 were used as spraying reagents to visualize the 
spots. Iodine was also used to detect the spots. 
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4.2 Plant Material 
The aerial parts of Rhododendron lepidotum were collected from Sonamarg, Kashmir 
in September 2007. After proper identification a voucher specimen (No. 1455/93) was 
deposited in the herbarium of the institute. 
 
4.3 Extraction and Isolation 
Shade-dried and coarsely powdered plant material (aerial part, 800 g) was defatted 
with hexane at room temperature for 48 hours to give 15g of hexane extract (1.87%). 
The defatted plant material was dried and extracted with methanol for 48 hours. The 
methanolic extract thus obtained was concentrated under reduced pressure to give 
crude extract, 112 g (14%). 
The methanolic extract was dissolved in the minimum amount of methanol and 
adsorbed on silica gel to form slurry. The dried slurry was subjected to column 
chromatography over silica gel. The column was eluted with different percentages of 
petroleum ether, dichloromethane, ethyl acetate and methanol in different proportions 
and the following fractions (100 ml each) were collected: 1-250 (petroleum ether - 
CH2Cl2, 1:1) (Fraction A), 251-375 (CH2Cl2) (Fraction B), 376-455 (CH2Cl2 - EtOAc, 
9:1) (Fraction C), 456-557 (CH2Cl2 - EtOAc, 7:3) (Fraction D), 558-591 (CH2Cl2 - 
EtOAc, 1:1) (Fraction E), 592-670 (EtOAc) (Fraction F), 671-720 (EtOAc - MeOH, 
9:1) (Fraction G), 721-773 (EtOAc - MeOH, 1:1) (Fraction H) and 774-797 (MeOH) 
(Fraction I). 
Fraction C (1.5 g) on keeping overnight deposited impure crystals, which were 
separated through filtration and purified by recrystallization to afford compound RL-2 
(500 mg). Sub fraction C-1 (850 mg) of fraction C was rechromatographed over silica 
 
Chapter-4                                   Experimental 
 
61 
gel and eluted with solvents like petroleum ether, chloroform and ethyl acetate in 
increasing order of polarity and afforded compound RL-1 (60 mg). 
Recolumn chromatography of fraction D (2 g) and elution with different solvents 
(hexane, chloroform and methanol) in increasing order of polarity afforded compound 
RL-3 (250 mg) and RL-4 (69 mg). Flow chart depicting isolation of compounds from 
the aerial part of R. lepidotum is shown in scheme 1. 
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Scheme 1: Flow chart depicting preparation of extracts and isolation of 
compounds from the aerial part of Rhododendron lepidotum. 
 
Rhododendron lepidotum 
Aerial part (800 grams) 
Hexane extract (15 g) Hexane extraction 
Marc 
Methanol extraction Marc 
Methanol extract (112 g) 
Column 
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P.E. - CH2Cl2, 
1:1 
Fr. C  
CH2Cl2 - EtOAc 
9:1 
Fr. E  
CH2Cl2 - EtOAc 
1:1 
Fr. G   
EtOAc - MeOH 
9:1 
Fr. I   
MeOH 
 
Fr. B 
CH2Cl2 
Fr. D  
CH2Cl2 - EtOAc 
7:3 
Fr. F  
EtOAc 
Fr. H   
EtOAc - MeOH 
1:1 
RL-1 
(60 mg) 
RL-4 
(69 mg) 
RL-3 
(250 mg) 
RL-2 
(500 mg) 
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4.3.1 RL-1 
Physical state  : Sharp needles 
Yield    : 0.0075% 
M.p.    : 225°C 
Rf    : 0.54 (CHCl3: MeOH; 8:2, v/v) 
UV (MeOH, λmax, nm) : 216, 245 and 322 
IR (KBr, ν , cm-1)  : 3411, 1680 
ESI-MS (m/z)  : 162 [M+], (Calcd. for C9H6O3) 
1H NMR   : Table 3.1 
13C-NMR   : Table 3.1 
 
4.3.2 RL-2 
Physical state  : Colourless needles 
Yield    : 0.062% 
M.p.    : 255°C 
Rf    : 0.66 (CH2Cl2: EtOAc; 1:1, v/v) 
UV (MeOH, λmax, nm) : 218, 267 and 302 
IR (KBr, ν , cm-1)  : 3419, 2870, 1725, 1463, 1023, 827 
ESI-MS (m/z)  : 178 [M+], (Calcd. for C9H6O4) 
1H NMR   : Table 3.3 
13C-NMR   : Table 3.3 
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4.3.3 RL-3 
Physical state  : Whitish amorphous powder 
Yield    : 0.031% 
M.p.    : 185°C 
Rf    : 0.72 (CHCl3: MeOH; 9:1, v/v) 
UV (MeOH, λmax, nm) : 219, 261 and 309 
IR (KBr, ν , cm-1)  : 3463, 1724, 1610, 1578) 
ESI-MS (m/z)  : 354 [M+], (Calcd. for C16H18O9) 
[α]D25     : 62° (c 1.0, MeOH) 
1H NMR   : Table 3.5 
13C-NMR   : Table 3.5 
 
4.3.4 RL-4 
Physical state  : Yellow powder 
Yield    : 0.0086% 
M.p.    : 195°C 
Rf    : 0.70 (CHCl3: MeOH; 9:1, v/v) 
UV (MeOH, λmax, nm) : 221, 264 and 307 
IR (KBr, ν , cm-1)  : 3535, 3320, 1723, 1613, 1579, 1084 
ESI-MS (m/z)  : 340 [M+], (Calcd. for C15H16O9) 
[α]D25    : 25° (c 1.0, MeOH)   
1H NMR   : Table 3.7 
13C-NMR   : Table 3.7 
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4.4 Preparation of extracts for biological screening 
The shade dried aerial part of Rhododendron lepidotum (150 g) was chopped, grinded 
and divided into three equal parts of 50 g each. One part was soaked in ethanol and 
labelled as A001, second part was soaked in 1:1 ethanol and water and labelled as 
A002 and the remaining part was soaked in water and labelled as A003. Each part was 
extracted four times at room temperature and concentrated under reduced pressure to 
give 5.5 g of A001, 3.5 g of A002 and 2.2 g of A003. 
 
4.5 Minimum inhibitory concentration assay 
All the four compounds isolated and the extracts prepared were tested against the 
following bacterial strains: Gram positive Staphylococcus aureus ATCC 29213, 
MRSA ATCC 15187; Gram negative Escherichia coli ATCC 8739 and Pseudomonas 
aeruginosa ATCC 9027. The bacterial cultures were maintained on Tryptone soya 
agar and stored at -70°C containing 50% glycerol. Ciprofloxacin obtained from 
Sigma-Aldrich was used as standard antibacterial agent for this study. Stock solution 
was prepared at 1mg/ml. 
MIC was determined as per the guidelines of Clinical and Laboratory Standards 
Institute (formerly the National Committee for Clinical Laboratory Standards) 
(Clinical and Laboratory Standards Institute, 2006). Bacterial suspensions were 
prepared by suspending 18-24 hrs grown bacterial cultures in sterile normal saline. 
The turbidity of the bacterial suspension was adjusted to 0.5 McFarland standards 
(equivalent to 1.5 × 108 CFU/ml) at wavelength 625nm. The 2-fold serial of 
compounds and extracts (stock solution prepared in DMSO) were prepared in MHB 
(Mueller Hinton Broth; DIFCO laboratories) in 100μl volume in 96-well U bottom 
microtitre plates (Tarson, Mumbai, India). The above mentioned bacterial suspension 
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was further diluted in the MHB and 100μl volume of this diluted inoculum was added 
to each well of the plate resulting in the final inoculum of 5 × 105 CFU/ml in the well 
and the final concentrations of the samples ranged from 2000 to 3.90μg/ml till the 10th 
column. Column 11 and column 12 containing 100μl and 200μl of medium without 
drug served as growth and media control respectively. The plates were incubated at 
37°C for 18 hrs and were read visually and the minimum concentration of the 
compound showing no turbidity was recorded as MIC. 
 
4.6 HPLC conditions 
The purity of all the isolated four compounds was checked by Thermo Finnigan 
HPLC system consisting of high pressure liquid chromatography pump (P 4000), an 
auto sampler (AS 3000), a column oven, a diode array detector (UV 6000 LP), 
Vacuum membrane degasser (SCM 1000) and System Integrator (SN 4000). 
ChromQuest 4.0 software was used for data analysis and processing. The 
measurements were carried out on RP 18 column (250mm x 4.6mm; particle size 
5mm; Merck, Germany) at 30°C. The injection volume was 5.0 μL, the mobile phase 
was Methanol: Acetonitrile: Water (45:15:40, v/v/v) and the flow rate was 0.5 
ml/min. A typical chromatogram with smooth base line was obtained using the 
isocratic elution of the compounds. 
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Summary 
The present work describes the isolation, identification and antibacterial activity 
studies of the chemical constituents of Rhododendron lepidotum. 
This dissertation is divided into four chapters: The Introduction, Review of Literature, 
Results and Discussion and Experimental. The first chapter describes an introduction 
to medicinal plants and their use in traditional system of medicine, current status of 
medicinal plants and natural products isolated thereof and isolation of 
phytochemicals/bioactive molecules from these plants which act as therapeutic agents. 
The second chapter includes the review of literature of ethno-pharmacology, 
chemistry and pharmacology of genus Rhododendron. The third chapter highlights the 
phytochemical investigation of Rhododendron lepidotum. Overall four natural 
compounds were isolated which were characterized and identified on the basis of 
physical properties, spectroscopic data analysis and chemical derivatisation. Out of 
four isolates two compounds were found as new molecules. 
The experimental part (fourth chapter) describes the collection of plant material, 
identification of the plant, preparation of extracts and isolation of natural products 
using column chromatography. The natural compounds thus isolated were subjected 
to evaluation of antibacterial activities. The four compounds isolated through column 
chromatography were identified as coumarins and were labelled as RL-1, RL-2, RL-
3 and RL-4. 
RL-1 was obtained as colorless crystalline needles from CHCl3-EtOAc fraction of 
methanol extract of the aerial part of Rhododendron lepidotum. The molecular 
formula was established as C9H6O3. It was identified as umbelliferone based on its 
physico-chemical properties and by comparing its spectral data with that reported in 
the literature. This compound is known to literature but is being reported for the first 
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time from this genus. Its antibacterial activity was not significant against the available 
Gram positive and Gram negative bacterial strains. 
RL-2 was obtained as colourless crystalline compound from CHCl3-EtOAc fraction 
of methanol extract of the aerial part of Rhododendron lepidotum. Its molecular 
formula was established as C9H6O4 and its structure was identified as daphnetin 
based on physicochemical properties and spectral data analysis. Although it is known 
to literature but is being reported for the first time from the genus Rhododendron. Its 
antibacterial activity was found to be good with MIC value of 125μg/ml against Gram 
positive Staphylococcus aureus, MRSA and Gram negative Escherichia coli and 
Pseudomonas aeruginosa. 
RL-3 was isolated as whitish amorphous powder from CHCl3-EtOAc fraction of 
methanol extract of the aerial parts of Rhododendron lepidotum. Its molecular formula 
was established as C16H18O9 and the structure was characterized as 7-O-β-D-
glucopyranosyl-8-methoxy benzopyranone based on chemical and spectral data. The 
compound is new to literature and is being reported for the first time. It showed a 
broad range of antibacterial activity against Gram positive Staphylococcus aureus, 
MRSA and Gram negative Escherichia coli and Pseudomonas aeruginosa with MIC 
250 μg/ml. 
RL-4, corresponding to molecular formula C15H16O9, was isolated as yellow 
amorphous powder from CHCl3-EtOAc fraction of methanol extract of the aerial part 
of Rhododendron lepidotum. Its structure was characterized as 7-hydoxy-8-O-β-
glycosyl-benzopyranone based on chemical and spectral data. It is also new to 
literature, reported for the first time. It showed moderate antibacterial activity against 
the above mentioned organisms.  
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Appendix I  :  List of Symbols/Abbreviations 
ATCC    American Type Culture Collection 
CC    Column chromatography 
CDCl3    Deuterated Chloroform 
CFU    Colony forming units 
cm-1    Centimeter inverse 
°C    Degree Celsius 
d    Doublet 
DEPT    Distortionless Enhancement by Polarization Transfer 
DMSO (d6)   Deuterated dimethyl sulphoxide 
ESI-MS   Electrospray Ionization Mass Spectrometry 
Fig.    Figure 
g/gm    Gram 
Hz    Hertz 
IR    Infrared 
J    Coupling constant 
m    Multiplet 
M    Molecular mass 
MeOD    Deuterated Methanol 
mg     Milligram 
μg     Microgram 
MHz     Mega Hertz 
MIC     Minimum Inhibitory Concentration 
mL/ml    Milliliter 
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mM    Millimolar 
M.p.    Melting point 
m/z    Mass to Charge ratio 
Na    Sodium 
NAM    Nutrient agar medium 
NBGP Nutrient broth containing 0.05% phenol red and 
supplemented with 10% glucose 
NMR    Nuclear Magnetic Resonance 
ppm    Parts Per Million 
RA    Reference antibiotic 
Rf    Retention factor 
s     Singlet 
TLC    Thin Layer Chromatography 
UV    Ultra Violet 
v/v    Volume by Volume 
α     Alpha 
β     Beta 
δ     Delta 
[α]D     Specific rotation 
λmax     Lamda maximum 
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Appendix II  :  List of Figures 
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1.1 An example of natural product drug discovery process. 
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2.2 Molecular structures of the bioactive flavonoids 
2.3 Molecular structures of histamine release inhibitory chemical constituents 
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3.1 HPLC spectrum of RL-1 
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3.3 HPLC spectrum of RL-2 
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3.5 Structure of RL-3 
3.6 HPLC spectrum of RL-3 
3.7 HPLC spectrum of RL-4 
3.8 Structure of RL-4 
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Appendix III  :  List of Tables 
No.   Title 
1.1 History of Natural Product Medicine 
2.1 Phytoconstituents of various species of Rhododendron 
3.1 1H and 13C NMR of RL-1 
3.2 Antibacterial activity of RL-1 against bacterial pathogens 
3.3 1H and 13C NMR of RL-2 
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Appendix IV  :  Phytochemical Tests 
1. Test for Carbohydrates: 100 mg of the substance is dissolved in 1 ml water and 
1drop of 1 % alcoholic solution of α-naphthol is added. 1 ml of conc. H2SO4 is added 
through the sides of test tube so that it forms a heavy layer at the bottom. A deep 
violet colour at the liquid junction confirms the presence of carbohydrates 
2. Test for Coumarins: A few mg of the compound is dissolved in methanol/ethanol 
and alcoholic KOH is added. Yellow colour which disappears on adding conc. HCl 
indicates the presence of coumarins. 
3. Test for Flavonoids: Dissolve a few mg of the compound in methanol or ethanol, 
add Mg powder/turnings and 5 M HCl. Flavonoids give deep red or magneta colour 
4. Test for Terpenoids: A few mg of substance is dissolved in chloroform and acetic 
anhydride, followed by sulphuric acid. Pink colour indicates the presence of 
terpenoids. 
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Appendix V  :  Spray Reagents 
1. Anisaldehyde-sulphuric acid reagent: 0.5 ml of anisaldeyde is mixed with 10 ml 
glacial acetic acid, followed by 85 ml methanol and 5 ml conc. H2SO4 
2. Cerric suplphate reagent: 1 g of Ce(SO4)2 is dissolved in 10 ml of conc. H2SO4 
and made upto 100 ml with distilled water 
3. Ferric chloride reagent: To 5 % solution of FeCl3, NH4OH solution is added with 
shaking drop by drop till the permanent precipitate is obtained (or) 1% Ferric (III) 
Chloride in Methanol/water (1:1). 
